about
Deadly allies: the fatal interplay between platelets and metastasizing cancer cellsADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy.Adhesion maturation of neutrophils on nanoscopically presented platelet glycoprotein Ibα.Circular, nanostructured and biofunctionalized hydrogel microchannels for dynamic cell adhesion studiesVWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice.Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event.Neutrophil extracellular traps: protagonists of cancer progression?Nanoscale integrin ligand patterns determine melanoma cell behavior.NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.PAD4 Deficiency Decreases Inflammation and Susceptibility to Pregnancy Loss in a Mouse Model.Peptidylarginine deiminase 4 promotes age-related organ fibrosisNanoscale Tuning of VCAM-1 Determines VLA-4-Dependent Melanoma Cell Plasticity on RGD Motifs.Constitutive and functionally relevant expression of JAM-C on platelets.Inhibition of platelet GPIb alpha and promotion of melanoma metastasis.Sexy again: the renaissance of neutrophils in psoriasis.The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis.Chromatin swelling drives neutrophil extracellular trap releaseControl of Integrin Affinity by Confining RGD Peptides on Fluorescent Carbon NanotubesThe power from within - understanding the driving forces of neutrophil extracellular trap formation
P50
Q24623647-6D566DF6-9EBD-492E-BF1A-5E002913ABEEQ33423350-F07F799C-4188-477A-9D58-66CDF4D9E271Q34006362-549C1A48-9F54-42E5-A54F-A1CA6FB8F5F9Q36253054-5505FA33-A0D5-4876-B5A8-5F2599506F26Q37429699-1B4815FD-2967-413E-A4B3-2321253DCE0CQ37513908-C88F135F-0C71-4E61-A1EA-DC4762D3EE76Q38784271-3CE1B273-1519-432D-9B81-E9C90C5071B9Q38961706-D08E3FE8-0F47-401E-A48E-DE629F82BF7AQ39770370-66C18AFF-CE2A-4297-8C73-71E443D84CE7Q40398309-6531F389-3DC0-4A44-AC6A-D190F4169615Q42323494-6D540394-1FF8-4B15-B9F4-9498E147B34AQ49989677-0FD2248F-4435-43D0-8B10-DB5D8B336716Q50234455-6693B5A7-8E8D-4EC1-B17B-C5B884B374A7Q50584072-6B001099-A1E5-433C-88E8-85237DAE08FDQ53096910-19571B66-02C1-4898-B0E0-D21841C87F56Q55386458-0EF204A2-9755-447B-ADD6-A71150C17264Q58740902-72E87F21-F133-4583-8C4F-9F8B1FF4796BQ88512236-6C8674FD-9991-49E3-ACE4-F71C2C7F8DC2Q90198964-1DC77B7F-698E-4CCA-84CB-0E5AC88AC947
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Luise Erpenbeck
@ast
Luise Erpenbeck
@en
Luise Erpenbeck
@es
Luise Erpenbeck
@nl
type
label
Luise Erpenbeck
@ast
Luise Erpenbeck
@en
Luise Erpenbeck
@es
Luise Erpenbeck
@nl
prefLabel
Luise Erpenbeck
@ast
Luise Erpenbeck
@en
Luise Erpenbeck
@es
Luise Erpenbeck
@nl
P106
P31
P496
0000-0002-6561-472X